Results 41 to 50 of about 1,218,098 (252)
Arterial Hypertension and Risk of Mortality in Patients with COVID-19 Infection
Southeastern European Medical Journal, 2022 COVID-19 is currently a major global health concern. Among many unanswered questions related to COVID-19, some of the most debated ones are those concerning arterial hypertension.
Nikolina Bukal +8 more
doaj +1 more source
The kidney in arterial hypertension [PDF]
Nephrology Dialysis Transplantation, 2001 The kidney facilitates the development of arterial hypertension and suffers its consequences. Once renal damage is clinically manifested, a clear increase in cardiovascular risk appears. The coincidence of renal and cardiovascular damage strengthens the need for therapies attempting the simultaneous protection of both the kidney and the cardiovascular ...
L M, Ruilope, J L, Rodicio
openaire +2 more sources
Рациональная фармакотерапия в кардиологии, 2015 Aim: to study cerebral blood flow and cholesterol metabolism in menopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations in these patients during 6-month antihypertensive and
V. V. Yakusevich +3 more
doaj +1 more source
Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review
International Journal of Inflammation, 2023 Background. Overweight and obesity are global health issues, impacting a significant portion of young adults. Obesity is a complex condition influenced by genetics and environmental factors, leading to increased susceptibility to cardiovascular diseases (
Jorge da Silva Pinho-Jr +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2023 Pulmonary arterial hypertension (PAH) is a disease characterized by elevated pulmonary vascular resistance and pulmonary artery pressure. Mortality remains high in severe cases despite significant advances in management and pharmacotherapy.
Jakob Körbelin +10 more
doaj +1 more source
ERJ Open Research, 2023 Background The 2022 ESC/ERS guidelines on pulmonary hypertension recommend noninvasive risk assessments based on three clinical variables during follow-up in patients with pulmonary arterial hypertension (PAH).
Jonna Ostermann +6 more
doaj +1 more source
Effect of Pomegranate Extract (Punica Granatum L) on Pulmonary Arterial Pressure in Sprague Dawley Rat with Pulmonary Arterial Hypertension [PDF]
, 2020 Congenital heart disease causes pulmonary arterial hypertension, heart failure, and early death. Pulmonary arterial hypertension causes pulmonary arterial wall remodeling, inflammation, deposition of extracellular matrix protein, collagen synthesis, and ...
Taufiq Hidayat, - +2 more
core +1 more source
Immunity, Inflammation and Disease, 2021 Introduction Although most patients recover within several weeks after acute COVID‐19, some of them develop long‐lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID‐19.
Nikolina Basic‐Jukic +7 more
doaj +1 more source